David Baxter PhD
Late Founder
ADHD Medications: Neurotransmitters to the Rescue
by Dr Charles Parker, CorePsychBlog
November 2, 2009
[T]he evolving neuroscience is taking us in new intervention directions.
ADHD medications, my friends, are evolving dramatically. Intuniv, the new ADHD medication, [not a stimulant, but rather an alpha 2A agonist] by Shire will be in your pharmacies soon, and the pharmacology, the indications, the new science is simply dramatic.
If you are a professional on any level, and can attend one of the launch dinners in your town, I strongly recommend that you take an evening to see evolved neurophysiology at work. That α2A receptor, that quite different medication, will help change the way we think about medications for ADHD in the future. More about that later, stay tuned to CorePsych Blog for the details, ? and watch my YouTube Channel at DrCharlesParker for a pithy report on our office findings with Intuniv ? likely next weekend.
...more
by Dr Charles Parker, CorePsychBlog
November 2, 2009
[T]he evolving neuroscience is taking us in new intervention directions.
ADHD medications, my friends, are evolving dramatically. Intuniv, the new ADHD medication, [not a stimulant, but rather an alpha 2A agonist] by Shire will be in your pharmacies soon, and the pharmacology, the indications, the new science is simply dramatic.
If you are a professional on any level, and can attend one of the launch dinners in your town, I strongly recommend that you take an evening to see evolved neurophysiology at work. That α2A receptor, that quite different medication, will help change the way we think about medications for ADHD in the future. More about that later, stay tuned to CorePsych Blog for the details, ? and watch my YouTube Channel at DrCharlesParker for a pithy report on our office findings with Intuniv ? likely next weekend.
...more
